Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018

Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during transurethral resection of bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and reduces recurrence rates. Flexible BLC was approved by the FDA in 2018 for use in the surveillance setting and was demonstra...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nat Rev Urol
Autori principali: Lotan, Yair, Bivalacqua, Trinity J., Downs, Tracy, Huang, William, Jones, Jeffrey, Kamat, Ashish M., Konety, Badrinath, Malmström, Per-Uno, McKiernan, James, O’Donnell, Michael, Patel, Sanjay, Pohar, Kamal, Resnick, Matthew, Sankin, Alexander, Smith, Angela, Steinberg, Gary, Trabulsi, Edouard, Woods, Michael, Daneshmand, Siamak
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2019
Soggetti:
Consensus Statement
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7136177/
https://ncbi.nlm.nih.gov/pubmed/31019310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41585-019-0184-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi